Yizhou Jiang

28PUBLICATIONS
97CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 04, 2026
Migration of immune cells in tumors and inflammation: molecular mechanisms and therapeutic targets.

|Jul 04, 2026
ZNF689 loss impairs homologous recombination sensitizing triple-negative breast cancer to combined PARP and PD-L1 inhibition.

|Jun 18, 2026
Spatially interpretable artificial intelligence framework to tailored neoadjuvant dual HER2 blockade in HER2-positive breast cancer.

|Mar 11, 2026
Phase separation of DDHD2 remodels lipid metabolism to dictate treatment sensitivity in luminal breast cancer.

Xiao-Hong Ding, Fenfang Chen, Fan Yang

|Feb 15, 2026
NK Cell Activation by Platinum Boosts Immunotherapy in HR+/HER2- Breast Cancer.

Yi-Yu Chen, Yi-Fan Zhou, Xuan Qi

|Sep 10, 2025
Interferon-induced senescent CD8+ T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer.

Tong Fu, Xi Jin, Min He

Pageof 5

Frequent Collaborators

17 joint publications

Zhi-Ming Shao

7 joint publications

Yi Xiao

6 joint publications

Ding Ma

4 joint publications

Xi Jin